Ford is promising to deliver an EV truck next year that starts at $30,000 and can compete with Chinese automakers without undermining profit margins. A combination of 3D-printed Lego-like parts, ...

Ford’s push to develop affordable EVs is also a fight against physics itself. Every bit of inefficiency caused by drag robs ...

Separating members from the greater company powers innovation, says Alan Clarke, executive director of advanced EV development.

2015-2017 F-150 trucks could have a sudden and uncommanded downshift.

Nearly 1.3 million 2015-2017 model year Ford F-150 units are under federal investigation for a previously probed issue, after an initial NHTSA investigation and subsequent recall allegedly failed to ...

The Ford Motor Company is ending this year with yet another massive recall. On this occasion, the recall population comprises 272,645 vehicles equipped with integrated park modules that may fail to ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...